Thyrotropin Modifies Activation of Nuclear Factor KappaB by Tumour Necrosis Factor Alpha in Rat Thyroid Cell Line
Overview
Authors
Affiliations
We have recently demonstrated that nuclear factor kappaB (NF-kappaB) mediates the tumour necrosis factor alpha (TNF-alpha)-dependent expression of the gene encoding interleukin 6 (IL-6) in rat thyroid FRTL-5 cells cultured in the presence of thyrotropin (TSH). In the present study we investigated how TSH is involved in the activation of NF-kappaB by TNF-alpha in the cells. Electrophoretic mobility-shift assay revealed that, in the absence of TSH, TNF-alpha activated a single protein-DNA complex containing the p50 subunit but not other NF-kappaB subunits such as p65. In contrast, two distinct protein-DNA complexes were activated in the presence of TSH: the faster-migrating complex contained only p50 subunit; the slower-migrating complex consisted of p65-p50 heterodimer. This TSH effect was mimicked by forskolin and thyroid-stimulating antibodies obtained from patients with Graves's disease, suggesting that an increase in intracellular cAMP is responsible for the induction of different NF-kappaBs by TNF-alpha. A transient transfection study with a luciferase reporter gene driven by multimerized NF-kappaB sites demonstrated that TNF-alpha increased the luciferase activities only in the presence of TSH, and that this increase was inhibited by the co-transfection of mutant p65, which prevented the function of wild-type p65 in a dominant-negative manner. Accordingly, TNF-alpha activated the expression of the IL-6 gene in the presence of TSH but not in its absence. Although the expression of the p105 gene, another known target for NF-kappaB, was increased by TNF-alpha in the absence of TSH, the presence of TSH further increased the mRNA level. Taken together, these observations indicate that the presence of TSH is crucial for the NF-kappaB-mediated actions of TNF-alpha on thyroid follicular cells.
Giuliani C, Verrocchio S, Verginelli F, Bucci I, Grassadonia A, Napolitano G Front Endocrinol (Lausanne). 2021; 12:749609.
PMID: 34938270 PMC: 8685237. DOI: 10.3389/fendo.2021.749609.
Reale C, Porreca I, Russo F, Marotta M, Roberto L, Russo N Sci Rep. 2018; 8(1):16324.
PMID: 30397221 PMC: 6218492. DOI: 10.1038/s41598-018-34427-2.
The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer.
Giuliani C, Bucci I, Napolitano G Front Endocrinol (Lausanne). 2018; 9:471.
PMID: 30186235 PMC: 6110821. DOI: 10.3389/fendo.2018.00471.
Cyclic AMP: a selective modulator of NF-κB action.
Gerlo S, Kooijman R, Beck I, Kolmus K, Spooren A, Haegeman G Cell Mol Life Sci. 2011; 68(23):3823-41.
PMID: 21744067 PMC: 11114830. DOI: 10.1007/s00018-011-0757-8.
Bishnoi M, Chopra K, Rongzhu L, Kulkarni S Neurotox Res. 2010; 20(3):215-25.
PMID: 21076901 DOI: 10.1007/s12640-010-9229-4.